Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09HIM
|
|||
Former ID |
DNC013541
|
|||
Drug Name |
XR-9504
|
|||
Synonyms |
XR-9504; CHEMBL258896; SCHEMBL7168501
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C34H35N3O4
|
|||
Canonical SMILES |
CC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2C(=O)NC3=CC=C(C=C3)CCN4CCC5=CC(=C(C=C5C4)OC)OC
|
|||
InChI |
1S/C34H35N3O4/c1-23-8-12-25(13-9-23)33(38)36-30-7-5-4-6-29(30)34(39)35-28-14-10-24(11-15-28)16-18-37-19-17-26-20-31(40-2)32(41-3)21-27(26)22-37/h4-15,20-21H,16-19,22H2,1-3H3,(H,35,39)(H,36,38)
|
|||
InChIKey |
YKXTXQJFMGBJLD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Multidrug resistance protein 1 (ABCB1) | Target Info | Inhibitor | [1] |
Multidrug resistance-associated protein 1 (ABCC1) | Target Info | Inhibitor | [1] | |
KEGG Pathway | ABC transporters | |||
Sphingolipid signaling pathway | ||||
Vitamin digestion and absorption | ||||
MicroRNAs in cancer | ||||
Bile secretion | ||||
NetPath Pathway | IL6 Signaling Pathway | |||
IL2 Signaling Pathway | ||||
TCR Signaling Pathway | ||||
Pathway Interaction Database | S1P1 pathway | |||
Sphingosine 1-phosphate (S1P) pathway | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Cobalamin (Cbl, vitamin B12) transport and metabolism | |||
ABC-family proteins mediated transport | ||||
WikiPathways | Arachidonic acid metabolism | |||
Irinotecan Pathway | ||||
Metabolism of water-soluble vitamins and cofactors | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | ||||
Abacavir transport and metabolism | ||||
Multi Drug Resistance Protein 1 (Glycoprotein 1) Regulation | ||||
Integrated Pancreatic Cancer Pathway | ||||
Allograft Rejection | ||||
Drug Induction of Bile Acid Pathway | ||||
Codeine and Morphine Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors. Bioorg Med Chem. 2008 Mar 1;16(5):2448-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.